Author:
Meltzer Mirjam E.,Doggen Carine J. M.,de Groot Philip G.,Rosendaal Frits R.,Lisman Ton
Reference34 articles.
1. PAI-1 and the metabolic syndrome: links, causes, and consequences;Alessi;Arteriosclerosis, Thrombosis, and Vascular Biology,2006
2. Plasminogen activator inhibitor-1, adipose tissue and insulin resistance;Alessi;Current Opinion in Lipidology,2007
3. Weak and non-independent association between plasma TAFI antigen levels and the insulin resistance syndrome;Aubert;Journal of Thrombosis and Haemostasis,2003
4. Curiouser and curiouser: recent advances in measurement of thrombin-activatable fibrinolysis inhibitor (TAFI) and in understanding its molecular genetics, gene regulation, and biological roles;Boffa;Clinical Biochemistry,2007
5. The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis;Burns;Journal of the American College of Cardiology,2002
Cited by
60 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献